Medication info

Maxiblue 5 Injection

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Zinc Sulfate Hydrate›4.39mg / 1mLCupric Sulfate Hydrate›1.57mg / 1mLManganese Sulfate Hydrate›0.308mg / 1mLChromic Chloride Hydrate›20.5μg / 1mLSelenious Acid›32.7μg / 1mL
Manufacturer / importer
Guju Pharmaceutical Co., Ltd.
Appearance
Colorless or pale blue transparent liquid without odor, contained in a colorless transparent vial for injection.
Packaging
(10mL/vial)x10
Approval status
Active

MFDS item code 201708386 · Notified 2017.12.18

Summary

Main use
Prevention of trace element (zinc, copper, etc.) deficiencies during parenteral nutrition
Who receives it
Adults · Children
Adult administration
Use as prescribed by a physician, and measure plasma trace element levels to guide dose adjustment. Permitted dosage range (for intravenous administration) Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4㎎ daily Copper: 0.5∼1.5㎎ daily Manganese: 0.15∼0.8㎎ daily Chromium: 10∼15㎍ daily Selenium: 20∼40㎍ daily Other Patients with metabolically stable small intestinal fluid loss: an additional 12.2㎎/L (volume of small intestinal fluid lost) or 17.1㎎/㎏ (stool output) Patients in an acute catabolic state: 4.5∼6㎎ daily Patients with metabolically stable small intestinal fluid loss: 20㎍ daily Deficiency due to long-term parenteral nutrition: 100㎍ daily may be used for 24∼31 days.
Child administration
Children 5 years and younger: zinc 100㎍/㎏ of body weight daily, copper 20㎍/㎏ of body weight daily, manganese 2∼10㎍/㎏ of body weight daily, chromium 0.14∼0.20㎍/㎏ of body weight daily, selenium 3㎍/㎏ of body weight daily

Ingredients

Manufacturer
Guju Pharmaceutical Co., Ltd.

Efficacy & effects

Prevention of trace element (zinc, copper, etc.) deficiencies during parenteral nutrition

View approved original text

During intravenous nutrition supply, trace elements such as zinc, copper, manganese, selenium, and chromium are essential for maintaining normal physiological functions and metabolic processes in the body. Therefore, they are supplied together to achieve nutritional balance and assist recovery.

How it is given

Adult administration

Use as prescribed by a physician, and measure plasma trace element levels to guide dose adjustment. Permitted dosage range (for intravenous administration) Patients receiving parenteral nutrition who are metabolically stable Zinc: 2.5∼4㎎ daily Copper: 0.5∼1.5㎎ daily Manganese: 0.15∼0.8㎎ daily Chromium: 10∼15㎍ daily Selenium: 20∼40㎍ daily Other Patients with metabolically stable small intestinal fluid loss: an additional 12.2㎎/L (volume of small intestinal fluid lost) or 17.1㎎/㎏ (stool output) Patients in an acute catabolic state: 4.5∼6㎎ daily Patients with metabolically stable small intestinal fluid loss: 20㎍ daily Deficiency due to long-term parenteral nutrition: 100㎍ daily may be used for 24∼31 days.

Child administration

Children 5 years and younger: zinc 100㎍/㎏ of body weight daily, copper 20㎍/㎏ of body weight daily, manganese 2∼10㎍/㎏ of body weight daily, chromium 0.14∼0.20㎍/㎏ of body weight daily, selenium 3㎍/㎏ of body weight daily

Precautions

This drug should not be used in premature infants or newborns because the benzyl alcohol component can cause serious respiratory problems in premature infants. When using this drug, it should be diluted and administered directly to avoid phlebitis, as administering undiluted can cause this issue. Additionally, since this drug is a hypotonic solution, it should only be used for mixed injections. If toxic symptoms occur during the administration of this drug, the administration must be stopped immediately. In particular, patients with impaired kidney function and premature infants are at higher risk of toxicity due to the aluminum component included in this drug if used for a prolonged period. Trace elements such as zinc, copper, manganese, chromium, and selenium included in this drug generally do not show toxicity at normal doses, but the doctor should carefully verify the patient’s condition and required dosage before administration and frequently check blood concentrations. Patients with renal failure are at risk of zinc accumulation in the body, and patients with biliary obstruction may accumulate copper and manganese, so caution is needed. Additionally, diabetic patients should check whether the chromium component affects blood sugar control. The safety of this drug has not been sufficiently validated during pregnancy, so it should only be used in pregnant women or women of childbearing age when the therapeutic benefit outweighs the risk. In cases of overdose, toxic symptoms related to zinc, copper, chromium, and selenium may occur, so caution is advised, and particularly, excessive zinc intake can lead to serious side effects. Immediate appropriate action should be taken if overdose is suspected. This drug should not be used without a doctor’s prescription, and when mixed with non-oral nutritional solutions, sterile conditions must be maintained, and it must be ensured that there is no discoloration or particulates.

Side effects

  • Rapid breathing symptoms
  • sweating
  • altered consciousness
  • blurred vision
  • tachycardia
  • hypothermia
  • hyperamylasemia
  • hypotension
  • pulmonary edema
  • diarrhea
Show 31 more
  • vomiting
  • jaundice
  • decreased urine output
  • exhaustion
  • behavioral changes
  • progressive wasting syndrome
  • photophobia
  • peripheral edema
  • nausea
  • ulcers
  • gastrointestinal disorders
  • renal dysfunction
  • liver dysfunction
  • seizures
  • coma
  • hair loss
  • weakened nails
  • dermatitis
  • dental damage
  • irritability
  • depression
  • metallic taste
  • sweating
  • garlicky odor during respiration
  • orthostatic shock
  • vascular congestion
  • pulmonary bleeding
  • pulmonary congestion
  • pulmonary edema
  • gastric mucosal discoloration
  • coma

Not everyone experiences these, and they can vary from person to person.

Storage

This drug should be stored in a sealed container to protect it from air and moisture. It is advisable to maintain a storage temperature between 15°C and 30°C. By storing it this way, the effectiveness of the drug can be securely maintained for a prolonged period.

Appearance and packaging

Appearance

Colorless or pale blue transparent liquid without odor, contained in a colorless transparent vial for injection.

Package unit

(10mL/vial)x10

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.